Burning Rock Biotech (BNR) Non-Current Assets (2019 - 2026)

Burning Rock Biotech's Non-Current Assets history runs 8 years deep, the most recent figure standing at $12.6 million for Q1 2026.

• In Q1 2026, Non-Current Assets fell 2.01% year-over-year to $12.6 million; the TTM figure through Mar 2026 stood at $12.6 million (down 2.01% YoY), while the FY2025 annual figure was $11.7 million, down 21.46% from the prior year.
• Non-Current Assets for Q1 2026 stood at $12.6 million, up from $11.5 million in the prior quarter.
• The five-year high for Non-Current Assets was $66.6 million in Q1 2022, with the low at $10.2 million in Q3 2025.
• The 5-year median for Non-Current Assets is $27.4 million (2023), against an average of $29.4 million.
• The sharpest annual moves came in 2022 and 2025: Non-Current Assets jumped 60.36% in 2022, then plunged 64.09% in 2025.
• Burning Rock Biotech's Non-Current Assets stood at $46.2 million in 2022, then sank by 53.15% to $21.7 million in 2023, then slumped by 30.12% to $15.1 million in 2024, then declined by 23.79% to $11.5 million in 2025, then rose by 9.1% to $12.6 million in 2026.
• Business Quant data shows BNR's Non-Current Assets at $12.6 million in Q1 2026, $11.5 million in Q4 2025, and $10.2 million in Q3 2025.